Sysmex and bioMérieux Form a Global Partnership for Urinary Screening in Microbiology
Sysmex Corporation and bioMérieux have signed an agreement today by which bioMérieux will become Sysmex's global partner for distributing its UF-1000i urinalysis system in microbiology laboratories. According to the companies, this synergistic partnership between two major players in the in vitro diagnostic market brings together Sysmex's recognized expertise in diagnostic analyzers and bioMérieux's leadership position in microbiology.
Current urinary screening methods, mainly based on microscope cell numeration, are still very manual, time-consuming and the source of errors. Sysmex has developed the fluorescence flow cytometry UF-1000i urinalysis system, a highly standardized and automated solution. bioMérieux will provide its extensive customer base with this new technology and leverage its expertise and reputation in microbiology to expand the market. Commercialization by bioMérieux will start in Europe in September 2007 and be followed by the U.S. and other countries at the beginning of 2008.
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.

Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Last viewed contents
Oncolytics Biotech Inc. has been granted patent for extracting virus from cell culture
SEQUENOM Secures Rights to Key Non-Invasive Prenatal Diagnostic Intellectual Property
Evogene and Zeraim Gedera Salt Tolerant Tomato Collaboration Advances to Second Phase
Heptares granted patents covering stabilised receptor technology in Europe and Japan - Key patent grants protect Heptares’ leading position in GPCR-targeted drug design and discovery
Pevion’s therapeutic Candida vaccine shows robust systemic and mucosal immunogenicity

Covestro and Genomatica produce important chemical raw material using biotechnology - Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics
Amarin corporation Appoints Colin W. Stewart as President and Chief Executive Officer
Discovery of quantum vibrations in 'microtubules' corroborates theory of consciousness

Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”
Genmab and Seattle Genetics Enter Into Antibody-Drug Conjugate Research Collaboration
